Drug · DIN 02558262
PIASKY
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 10, 2025; first marketed November 10, 2025.
- Drug Identification Number (DIN)
- 02558262
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Intravenous; Subcutaneous
- Therapeutic class (ATC)
- Crovalimab L04AJ07
- Class
- Human
- Record last updated
- August 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CROVALIMAB | 170 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 4, 2025: NOC 35476New Drug Submission (NDS)